| Page 1166 | Kisaco Research
Interview: Roberto De Luca, Head of therapeutic Antibodies, Philochem/Philogen
Interview: Jeanette Leusen, Head of the Immunotherapy Group and UMAB, UMCU
Model Risk Management for the Machine Learning Era
Stealth Licensing
Collaborative standardisation and disruptive innovation: summary paper developed by Haris Tsilikas, Max Plank Institute, for 4iP Council.
Why researchers need an IP strategy
 

Nicholas New

CEO
Optalysys

Nicholas New

CEO
Optalysys

Nicholas New

CEO
Optalysys
 

Yael Alter

Chief Executive Officer
NR Soos Technology

Yael Alter

Chief Executive Officer
NR Soos Technology

Yael Alter

Chief Executive Officer
NR Soos Technology
 

Dr Eve Hanks

Chief Executive Officer & Founder
MI:RNA Diagnostics

Dr Eve Hanks

Chief Executive Officer & Founder
MI:RNA Diagnostics

Dr Eve Hanks

Chief Executive Officer & Founder
MI:RNA Diagnostics
 

Eleanor Wheeler

Associate Director of Research & Policy
The Health Policy Partnership

Eleanor Wheeler

Associate Director of Research & Policy
The Health Policy Partnership

Eleanor Wheeler

Associate Director of Research & Policy
The Health Policy Partnership